13F-HR filed by Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-12, with 8 holding rows worth $594,472,000.
- Accession
- 0001104659-20-123944
- Filer
- CIK 1767432
- Filed
- 2020-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 8 entries on the cover page, a total value of $594,472,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $594,472,000 with VALUE read as thousands by filing date, 13F file number 028-19068. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DRAFTKINGS INC | 26142R104 | COM CL A | 8,284,008 | $487,431,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 3,833,120 | $52,169,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 1,306,965 | $24,898,000 | thousands by filing date | |
| ROKU INC COM CL A | 77543R102 | Stock | 57,707 | $10,895,000 | thousands by filing date | |
| SNAP INC | 83304A106 | CL A | 245,559 | $6,412,000 | thousands by filing date | |
| DATADOGINCCLASSA | 23804L103 | STOK | 56,616 | $5,784,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 292,184 | $4,432,000 | thousands by filing date | |
| MIRAGEN THERAPEUTICS INC | 60463E103 | COM | 3,142,580 | $2,451,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-20-123944 | this filing | 2020-11-12 | acceptance time not in the bulk data set |